<DOC>
	<DOCNO>NCT02162056</DOCNO>
	<brief_summary>To evaluate safety , performance efficacy bioresorbable vascular scaffold ( BVS ) system patient coronary artery disease</brief_summary>
	<brief_title>Coronary Structural Interventions Ulm - Bioresorbable Vascular Scaffold</brief_title>
	<detailed_description>Patients coronary artery disease receive bioabsorbable vascular scaffold . Patients clinically follow period 10 year .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Unstable</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<criteria>coronary artery disease implantation least one bioresorbable vascular scaffold write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>